My NCBISign In
The Future of Smallpox Vaccination: is MVA the key?
Mark K Slifka
Med Immunol. 2005; 4: 2. Published online 2005 March 1. doi: 10.1186/1476-9433-4-2
PMCID:
PMC554756
Abstract Full Text PDF–290K

Is Cited by the Following 16 Articles in this Archive:

Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease
Joseph W Golden, Marina Zaitseva, Senta Kapnick, Robert W Fisher, Malgorzata G Mikolajczyk, John Ballantyne, Hana Golding, Jay W Hooper
Virol J. 2011; 8: 441. Published online 2011 September 20. doi: 10.1186/1743-422X-8-441
PMCID:
PMC3192780
Abstract Full Text PDF–2.0M Supplementary Material
Development of Vaccinia Reporter Viruses for Rapid, High Content Analysis of Viral Function at All Stages of Gene Expression
Ken Dower, Kathleen H. Rubins, Lisa E. Hensley, John H. Connor
Antiviral Res. Author manuscript; available in PMC 2012 July 1.
Published in final edited form as: Antiviral Res. 2011 July; 91(1): 72–80. Published online 2011 May 5. doi: 10.1016/j.antiviral.2011.04.014
PMCID:
PMC3177160
Free in PMC on 2012/07/01
Smallpox Vaccine Safety Is Dependent on T Cells and Not B Cells
Shari N. Gordon, Valentina Cecchinato, Vibeke Andresen, Jean-Michel Heraud, Anna Hryniewicz, Robyn Washington Parks, David Venzon, Hye-kyung Chung, Tatiana Karpova, James McNally, Peter Silvera, Keith A. Reimann, Hajime Matsui, Tomomi Kanehara, Yasuhiko Shinmura, Hiroyuki Yokote, Genoveffa Franchini
J Infect Dis. 2011 April 15; 203(8): 1043–1053. doi: 10.1093/infdis/jiq162
PMCID:
PMC3068024
Abstract Full Text PDF–880K
Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents
S Ramasamy, CQ Liu, H Tran, A Gubala, P Gauci, J McAllister, T Vo
Br J Pharmacol. 2010 October; 161(4): 721–748. doi: 10.1111/j.1476-5381.2010.00939.x
PMCID:
PMC2992890
Abstract Full Text PDF–1.8M Supplementary Material
Modified Vaccinia Virus Ankara Exerts Potent Immune Modulatory Activities in a Murine Model
Miriam Nörder, Pablo D. Becker, Ingo Drexler, Claudia Link, Volker Erfle, Carlos A. Guzmán
PLoS One. 2010; 5(6): e11400. Published online 2010 June 30. doi: 10.1371/journal.pone.0011400
PMCID:
PMC2900180
Abstract Full Text PDF–895K Supplementary Material
Can vaccinia virus be replaced by MVA virus for testing virucidal activity of chemical disinfectants?
Holger F Rabenau, Ingrid Rapp, Jochen Steinmann
BMC Infect Dis. 2010; 10: 185. Published online 2010 June 23. doi: 10.1186/1471-2334-10-185
PMCID:
PMC2908096
Abstract Full Text PDF–537K
Control of vaccinia virus skin lesions by long-term-maintained IFN-γ+TNF-α+ effector/memory CD4+ lymphocytes in humans
Bénédicte Puissant-Lubrano, Philippe Bossi, Frederick Gay, Jean-Marc Crance, Olivia Bonduelle, Daniel Garin, François Bricaire, Brigitte Autran, Behazine Combadière
J Clin Invest. 2010 May 3; 120(5): 1636–1644. Published online 2010 April 1. doi: 10.1172/JCI38506
PMCID:
PMC2860918
Abstract Full Text PDF–1.0M
Studies of the Suitability of Fowlpox as a Decontamination and Thermal Stability Simulant for Variola Major
Amanda E. Chambers, Melissa M. Dixon, Steven P. Harvey
Int J Microbiol. 2009; 2009: 158749. Published online 2010 January 28. doi: 10.1155/2009/158749
PMCID:
PMC2817860
Abstract Full Text PDF–649K
New classes of orthopoxvirus vaccine candidates by functionally screening a synthetic library for protective antigens
Alexandre Borovkov, D. Mitch Magee, Andrey Loskutov, Jose A. Cano, Cheryl Selinsky, Jason Zsemlye, C. Rick Lyons, Kathryn Sykes
Virology. Author manuscript; available in PMC 2010 December 5.
Published in final edited form as: Virology. 2009 December 5; 395(1): 97–113. Published online 2009 October 2. doi: 10.1016/j.virol.2009.09.008
PMCID:
PMC2784938
Abstract Full Text PDF–1.5M
Application of pharmacogenomics to vaccines
Gregory A Poland, Inna G Ovsyannikova, Robert M Jacobson
Pharmacogenomics. Author manuscript; available in PMC 2010 March 1.
Published in final edited form as: Pharmacogenomics. 2009 May; 10(5): 837–852. doi: 10.2217/PGS.09.25
PMCID:
PMC2722448
Abstract Full Text PDF–349K
Immunogenicity of Recombinant Modified Vaccinia Ankara Following a Single or Multi-dose Vaccine Regimen in Rhesus Monkeys
Lauren E. Grandpre, Jonathan S. Duke-Cohan, Bonnie A. Ewald, Colleen Devoy, Dan H. Barouch, Norman L. Letvin, Ellis L. Reinherz, Lindsey R. Baden, Raphael Dolin, Michael S. Seaman
Vaccine. Author manuscript; available in PMC 2010 March 4.
Published in final edited form as: Vaccine. 2009 March 4; 27(10): 1549–1556. Published online 2009 January 23. doi: 10.1016/j.vaccine.2009.01.010
PMCID:
PMC2675192
Abstract Full Text PDF–1.0M
A Novel Replication-Competent Vaccinia Vector MVTT Is Superior to MVA for Inducing High Levels of Neutralizing Antibody via Mucosal Vaccination
Xiaoxing Huang, Bin Lu, Wenbo Yu, Qing Fang, Li Liu, Ke Zhuang, Tingting Shen, Haibo Wang, Po Tian, Linqi Zhang, Zhiwei Chen
PLoS ONE. 2009; 4(1): e4180. Published online 2009 January 13. doi: 10.1371/journal.pone.0004180
PMCID:
PMC2613559
Abstract Full Text PDF–306K
Personalized vaccines: the emerging field of vaccinomics
Gregory A Poland, Inna G Ovsyannikova, Robert M Jacobson
Expert Opin Biol Ther. Author manuscript; available in PMC 2010 March 3.
Published in final edited form as: Expert Opin Biol Ther. 2008 November; 8(11): 1659–1667. doi: 10.1517/14712598.8.11.1659
PMCID:
PMC2831634
Abstract Full Text PDF–62K
Monkeypox virus evades antiviral CD4+ and CD8+ T cell responses by suppressing cognate T cell activation
Erika Hammarlund, Anindya Dasgupta, Clemencia Pinilla, Patricia Norori, Klaus Früh, Mark K. Slifka
Proc Natl Acad Sci U S A. 2008 September 23; 105(38): 14567–14572. Published online 2008 September 16. doi: 10.1073/pnas.0800589105
PMCID:
PMC2567221
Abstract Full Text PDF–687K Supplementary Material
Characterization and Use of Mammalian-Expressed Vaccinia Virus Extracellular Membrane Proteins for Quantification of the Humoral Immune Response to Smallpox Vaccines
Alonzo D. García, Clement A. Meseda, Anne E. Mayer, Arunima Kumar, Michael Merchlinsky, Jerry P. Weir
Clin Vaccine Immunol. 2007 August; 14(8): 1032–1044. Published online 2007 June 27. doi: 10.1128/CVI.00050-07
PMCID:
PMC2044493
Abstract Full Text PDF–417K
Expression of CCL20 and Granulocyte-Macrophage Colony-Stimulating Factor, but Not Flt3-L, from Modified Vaccinia Virus Ankara Enhances Antiviral Cellular and Humoral Immune Responses
R. Chavan, K. A. Marfatia, I. C. An, D. A. Garber, M. B. Feinberg
J Virol. 2006 August; 80(15): 7676–7687. doi: 10.1128/JVI.02748-05
PMCID:
PMC1563727
Abstract Full Text PDF–477K
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk